EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequential Anabolic and Antiresorptive Treatment Promotes Medication‐Related Osteonecrosis of the Jaw in Mice

Seo-Yeong An iD, Hae-Seo Park, Reuben H Kim iD, Moon-Young Kim

Oral Diseases · 2026

DOI: 10.1111/odi.70417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2026. Verfasst von Seo-Yeong An und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan, Republic of Korea. Hauptthemen laut MEDLINE: Denosumab, Bone Density Conservation Agents, Antibodies, Monoclonal, Tooth Socket. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dankook University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effects of sequential administration of romosozumab and denosumab on post‐extraction socket healing and osteonecrosis development in a murine tooth extraction model.

Methods

Forty female mice were randomly assigned to four groups: control (Ctrl), romosozumab (Rm), denosumab (Dmab), and sequential romosozumab followed by denosumab (Rm + Dmab). After drug administration, bilateral maxillary first molars were extracted. Extraction socket healing was evaluated by micro‐computed tomography, histological analysis, and immunohistochemistry for receptor activator of nuclear factor κB ligand (RANKL), osteoprotegerin (OPG), and sclerostin.

Results

The Rm + Dmab group exhibited significantly less new bone formation and more necrotic bone in the extraction sockets than the other groups, accompanied by a marked reduction in osteoclast numbers. The Dmab‐only group showed a lower RANKL/OPG ratio. No significant differences in sclerostin expression were observed among groups.

Conclusions

Sequential administration of romosozumab followed by denosumab severely impaired extraction socket healing and induced osteonecrotic lesions in mice, resembling medication‐related osteonecrosis of the jaw (MRONJ). These findings suggest that such sequential antiresorptive therapy may increase the risk of MRONJ in patients undergoing dental extractions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabBone Density Conservation AgentsAntibodies, MonoclonalTooth SocketBisphosphonate-Associated Osteonecrosis of the JawAnimalsFemaleMiceRANK LigandTooth ExtractionX-Ray MicrotomographyOsteoprotegerinWound HealingOsteoclastsAdaptor Proteins, Signal TransducingDisease Models, Animal

Stichwörter der Autor:innen

MRONJdenosumabhealingosteoclastromosozumab

Substanzen

DenosumabRANK LigandBone Density Conservation AgentsAntibodies, MonoclonalromosozumabOsteoprotegerinSost protein, mouseAdaptor Proteins, Signal TransducingTnfrsf11b protein, mouseTnfsf11 protein, mouse

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan, Republic of Korea.
  • The Shapiro Family Laboratory of Viral Oncology and Aging Research, Los Angeles, California, USA.
  • UCLA Jonsson Comprehensive Cancer Centre, Los Angeles, California, USA.

ORCID-Profile: Seo-Yeong An, Reuben H Kim

Förderung

  • Dankook University

Zitieren

APA

An, S. Y., Park, H. S., Kim, R. H., & Kim, M. Y. (2026). Sequential Anabolic and Antiresorptive Treatment Promotes Medication‐Related Osteonecrosis of the Jaw in Mice. Oral Diseases. https://doi.org/10.1111/odi.70417

Vancouver

An SY, Park HS, Kim RH, Kim MY. Sequential Anabolic and Antiresorptive Treatment Promotes Medication‐Related Osteonecrosis of the Jaw in Mice. Oral Diseases. 2026. doi:10.1111/odi.70417

BibTeX
@article{An2026,
  author = {An, Seo-Yeong and Park, Hae-Seo and Kim, Reuben H and Kim, Moon-Young},
  title = {Sequential Anabolic and Antiresorptive Treatment Promotes Medication‐Related Osteonecrosis of the Jaw in Mice},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70417}
}
Kostenlos starten →